UNSPSC 51202205: Tabilautide

This classification denotes a biological response modifier, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) EZ61NB05TG. European Medicines Agency schedules Tabilautide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10793MIG. Tabilautide generally arises in the molecular formula C27H49N5O8.

UNSPSC 51202205 Tabilautide is a Commodity code that encompasses pharmaceutical products and therapeutic agents procured by state and local health departments, fire and rescue services, and emergency response agencies for injury treatment, pain management, and medical aid supply. State and local governments buy these products—including antiseptic sprays, hydrogen peroxide, pain relievers, bandages, and first aid supplies—primarily to support emergency responder health and wellness programs, occupational health clinics, and disaster preparedness inventories. Issuing bodies span fire and rescue departments (City of Tampa Fire Rescue), municipal public safety agencies (City of Tucson Fire and Police Departments), and state health authorities (Texas Health and Human Services Commission). The mix reflects both day-to-day operational procurement of medical consumables and strategic initiatives such as occupational health and pharmacy benefit program modernization.

Recent activity includes the City of Tucson's RFP for Athletic Training Services (posted May 13, 2026, due June 9, 2026) that bundles medical aid and treatment supplies into comprehensive injury prevention and rehabilitation programs for fire and police personnel; the City of Tampa Fire Rescue's ITB for Medical Aid Supplies (posted April 24, 2026, due April 9, 2025) covering 32 discrete items with annual quantities ranging from 1 to 2,700 units and a total department budget of $100,000, including set-aside discounts for Small Local Business Enterprises and Underutilized Woman and Minority-Owned Business Enterprises; and the Texas Health and Human Services Commission's Request for Information (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. Geographic spread centers on Arizona and Texas, with activity also in Florida. The code shows modest recent volume, concentrated among municipal fire and emergency response procurement and exploratory state pharmacy initiatives rather than broad health department purchasing.